USA
08048073451
+919226141973

janus kinase jak inhibitor

68179d65be22ee500d53ff54 Card 2

product image
Janus Kinase (JAK) inhibitor

Product Name: Ruxolitinib Cream (commonly marketed as Rutinib Cream 1.5%) Form: Topical cream for skin application Strength/Concentration: 1.5% w/w ruxolitinib (active ingredient) Composition : Active Ingredient: • Ruxolitinib 1.5% w/w — a Janus kinase (JAK1/JAK2) inhibitor that modulates inflammatory and immune signaling in the skin. Mechanism of Action : Ruxolitinib blocks JAK enzymes involved in immune signaling (JAK1 and JAK2). This reduces inflammation, modulates immune responses in the skin, and helps control inflammatory and pigmentary processes. Indications / Uses : This cream is used (on medical prescription) for the topical treatment of: Atopic dermatitis (eczema) — especially mild to moderate cases not adequately controlled by other topical therapies. Non-segmental vitiligo — to help promote repigmentation of depigmented skin patches in patients aged 12 years and older. Application & Administration : Apply a thin layer directly to affected skin areas as directed by your healthcare provider. Typically used twice daily on clean, dry skin, usually up to a limited body surface area. Avoid contact with eyes and mucous membranes. Rutinib cream contains ruxolitinib, a topical JAK (Janus kinase) inhibitor used to treat certain inflammatory and autoimmune skin conditions. Key Uses and Indications : Atopic Dermatitis (Eczema): Treats red, irritated, and itchy skin in patients with mild to moderate eczema. Vitiligo: Used for nonsegmental vitiligo in patients 12 and older, aiding in repigmentation of the skin. Mechanism of Action: As a Janus kinase (JAK) inhibitor, it works by suppressing immune responses in the skin to reduce inflammation. Rutinib Cream 1.5% (containing Ruxolitinib) is a prescription topical JAK inhibitor used for the short-term treatment of mild-to-moderate eczema (atopic dermatitis) and nonsegmental vitiligo in adults and children 12 years and older. It reduces itching, inflammation, and helps restore skin pigmentation. How It Works : Ruxolitinib blocks JAK1 and JAK2 enzymes, which are involved in inflammatory and immune signaling pathways. This helps : Decrease skin inflammation Reduce immune overactivity Support restoration of normal skin color in vitiligo

Phone Number

08048073451

Please keep 0 before dialling the number.

Mon-Thu: 10 AM - 2 PM • Fri: 3 PM - 7AM

Other Website Visit our other website
Address Washington , District of Columbia , District of Columbia

USA, United States, 20001